Back

Heart failure therapy optimization in myocardial infarction patients with systolic dysfunction during Phase 2 and 3 Cardiac Rehabilitation

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: From infarction to recovery: SGLT2 and rehabilitation in heart failure Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Salvador Cardona Tercero

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

6 More presentations in this session

Presentation thumbnail
Dapagliflozin attenuates post-infarction inflammation and remodeling via promoting metabolic reprogramming–driven cardiac lymphangiogenesis
Doctor Z. Zhang (CN)
Abstract
Presentation thumbnail
Does symptom profile modify revascularization benefit in ischemic LV dysfunction? A win ratio analysis pooling STICHES and REVIVED-BCIS2
Doctor G. Tong (New Haven, US)
Abstract
Presentation thumbnail
Effects of beta-blocker treatment on circulating biomarkers of fibrosis in patients with myocardial infarction without heart failure: A substudy of the BETAMI-DANBLOCK trial
Professor I. Lunde (Oslo, NO)
Abstract
Presentation thumbnail
Differences in survival outcomes and LVEF of self-expanding versus balloon expandable valves after TAVI in patients with severe cardiac dysfunction
Doctor A. Matta (Toulouse, FR)
Abstract
Presentation thumbnail
Reversal of residual left ventricular remodeling in corrected primary valvular regurgitation: is it different from dilated cardiomyopathy
Mr R. Zhang (Chengdu, CN)
Abstract

Access the full session

Session thumbnail
From infarction to recovery: SGLT2 and rehabilitation in heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure and early cardiac rehabilitation: pilot experience and definition of the patient journey
4 April 2025
thumbnail
Congress Session
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
18 May 2025
thumbnail
Congress Presentation
Heart Failure incidence following ST-elevation myocardial infarction: results from a contemporary cohort.
29 June 2021
thumbnail
Congress Presentation
The kinetic of left ventricle diastolic dysfunction during pharmacotherapy up-titration in patients with dilated cardiomyopathy.
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources